Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopropofol Dose Requirements for Painless Gastroscopy in Non-Obese vs Obese Adults
ChiCTR2500111058Phase 4Not yet recruiting
- Sponsor
- Zhejiang Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None and need for sedation for endoscopic examination (2 arms), sponsored by Zhejiang Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: ED50/ED90 for suppression of gastroscope insertion response and Comparison of ED50/ED90 between non-obese and obese patients. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
need for sedation for endoscopic examination
Beyond the preview
Go deeper on ChiCTR2500111058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111058.